SCIO-469: Clinical Trials

6 completed. 5 Phase 2, 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	5	Completed 5
Phase 1	1	Completed 1

Follow SCIO-469: new trials by email Literature Review of SCIO-469 trials Research Report on SCIO-469

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes. SCIO-469 - Bone Marrow Diseases, Myelodysplastic Syndromes	Phase 2	Completed	Scios, Inc.	62	2005-05-01	2013-11-07
Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma SCIO-469, SCIO-469 and bortezomib - Multiple Myeloma	Phase 2	Completed	Scios, Inc.	30	2004-11-01	2010-10-22
SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate SCIO-469, Placebo - Arthritis, Rheumatoid	Phase 2	Completed	Scios, Inc.	302	2004-07-01	2010-10-18
Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma SCIO-469, SCIO-469 and bortezomib - Multiple Myeloma	Phase 2	Completed	Scios, Inc.	62	2004-06-01	2010-10-18
Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving Methotrexate SCIO-469 - Rheumatoid Arthritis	Phase 2	Completed	Scios, Inc.	120		2010-04-27
A Study of Oral SCIO-469 Pharmacokinetics (Study of a Drug in the Body to Watch How the Drug is Absorbed, Distributed, Metabolized and Eliminated Over a Period of Time) in the Body of Female Patients With Active Rheumatoid Arthritis Oral SCIO-469 capsule - Rheumatoid Arthritis	Phase 1	Completed	Scios, Inc.	16		2011-05-19

Conditions studied

Arthritis, Rheumatoid (3)  ·  Multiple Myeloma (2)  ·  Bone Marrow Diseases (1)  ·  Bone Marrow Neoplasms (1)  ·  Hematologic Diseases (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasms, Plasma Cell (1)

Sponsors

Scios, Inc. (6)